Clin2
NCT07387588Possibly a fitNot yet recruiting

Anemia as a predictor of IBD outcomes

Inflammatory Bowel Diseases

Part of Digestive system clinical trials.

This study looks at whether anemia (low red blood cells) can help predict how inflammatory bowel disease (IBD) will progress. It aims to find out if tracking anemia can give clues about treatment and recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
83 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with ulcerative colitis or Crohn's disease (types of IBD).
  • You are being treated or followed at Assiut University Hospitals.
  • You are willing to sign a consent form to join the study.
  • You do not have other blood disorders (like aplastic anemia or sickle cell disease) unrelated to IBD.
  • You do not have severe kidney or liver failure, or other illnesses that cause anemia.
  • You have not had a blood transfusion in the last 3 months.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06995170Recruiting
Polyamines and IBD progression study

This study looks at how certain natural chemicals called polyamines relate to the activity of inflammatory bowel disease (IBD). It aims to understand if these chemicals can help predict disease progression.

Xi'an, Shaanxi
NCT07788131Not yet recruiting
Inflammatory markers and disease activity in inflammatory bowel disease

This study looks at whether certain blood markers can help measure disease activity in people with Crohn's disease or ulcerative colitis. It involves reviewing medical records and may include a colonoscopy if you have one done as part of your routine care.

NCT05653011Recruiting
Study outcomes in people with inflammatory bowel disease

This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.

Seongnam-si, Gyeonggi-do
NCT03809728Recruiting
Finding blood tests linked to outcomes in Crohn’s and colitis

This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.

Vandœuvre-lès-Nancy
NCT06680076Not yet recruiting
Study of fats in the blood and gut of people with IBD

This study looks at changes in fats (lipids) in the blood and the lining of the gut in people with inflammatory bowel disease (IBD). It may help researchers understand IBD better and find new ways to treat it.

Harbin, Heilongjiang
NCT06550310Recruiting
Nutrition and IBD treatment outcomes

This study looks at how nutrition affects people with IBD who are starting a new treatment or having surgery. Researchers want to find out if diet or body changes influence how well you recover.

London

Hear when a new Inflammatory Bowel Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.